Primary record
1-PROPANONE, 1-(4-((2-(2-AMINO-5-PYRIMIDINYL)-7-METHYL-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)-1-PIPERAZINYL)-2-HYDROXY-, (2S)-
- 库存
- 1,476 克
- 纯度
- 99.8 %
- CAS
- 1032754-93-0
化合物标识与属性
- CAS
- 1032754-93-0
- PubChem CID
- 25254071
- SMILES
- CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O
- Canonical SMILES
- Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12
名称与同义词
- Apitolisib
- GDC-0980
- 1032754-93-0
- apitolisibum
- GDC0980
- Apitolisib [USAN:INN]
- RG7422
- GNE 390
- Gne-390
- GDC-0980 (Apitolisib)
- UNII-1C854K1MIJ
- 1C854K1MIJ
- cc-6
- APITOLISIB [INN]
- Apitolisib (USAN/INN)
- APITOLISIB [USAN]
- RefChem:1077141
- D0N1BU
- D0O6VZ
- GDC 0980
- GDC-0980 (RG7422)
- Apitolisib (GDC-0980)
- APITOLISIB [WHO-DD]
- Apitolisib(GDC-0980)?
- RG 7422
- MFCD20274520
- CHEMBL1922094
- C23H30N8O3S
- SCHEMBL466297
- DTXSID50145738
- RG-7422
- GTPL7888
- orb1307117
- DTXCID1068229
- GDC-0980.1
- SCHEMBL29447291
- EX-A041
- QCR-182
- SYN1150
- YOVVNQKCSKSHKT-HNNXBMFYSA-N
- BDBM747327
- GLXC-90034
- AOB87742
- Apitolisib (GDC-0980, RG7422)
- BCP02622
- (S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one
- ABP000111
- BDBM50358204
- GDC-0980,RG7422
- GDC-0980/RG7422
- GDC0980(RG7422)
- NSC764091
- NSC799334
- s2696
- US12324807, Compound Apitolisib
- ZINC59224388
- AKOS027250725
- ACN-053695
- BCP9000717
- CCG-269678
- CS-0590
- DB12180
- NSC-764091
- NSC-799334
- RL00154
- SDCCGSBI-0654434.P001
- KS-0000079T
- GDC-0980 - RG7422
- NCGC00263109-03
- NCGC00263109-13
- AS-16289
- BC638866
- HY-13246
- G-038390
- AB0033740
- B2184
- G-038390.1
- NS00072853
- SW219472-1
- X7458
- J2.971.211E
- A11023
- D10543
- Q-4032
- GNE 390; GDC 0980; RG 7422
- A855664
- (2s)-1-(4-{[2-(2-Aminopyrimidin-5-Yl)-7-Methyl-4-(Morpholin-4-Yl)thieno[3,2-D]pyrimidin-6-Yl]methyl}piperazin-1-Yl)-2-Hydroxypropan-1-One
- CAS:1032754-93-0;GDC-0980
- GDC-0980,CAS:1032754-93-0
- BRD-K23228615-001-02-8
- BRD-K23228615-001-03-6
- Q27074481
- (2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one
- Ethanimidic acid, N-(2-chloro-3-pyridinyl)-, methyl ester
- RG7422, 1032754-93-0
- (S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperaz
- (S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one.
- (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one
- (2S)-1-(4-((2-(2-AMINOPYRIMIDIN-5-YL)-7-METHYL-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL(PIPERAZIN-1-YL)-2-HYDROXYPROPAN-1-ONE
- (2S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one
- (2S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one
- (2S)-1-[4-[[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-yl]methyl]piperazino]-2-hydroxy-1-propanone
- (2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholino-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxy-propan-1-one
- (S)-1-(4-((2-(2-AMINOPYRIMIDIN-5-YL)-7-METHYL-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)PIPERAZIN-1-YL)-2-HYDROXYPROPAN-1-ONE
- 1-PROPANONE, 1-(4-((2-(2-AMINO-5-PYRIMIDINYL)-7-METHYL-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)-1-PIPERAZINYL)-2-HYDROXY-, (2S)-
- 186031-00-5
- 6-[4-[(S)-2-Hydroxypropanoyl]piperazine-1-ylmethyl]-7-methyl-2-(2-aminopyrimidine-5-yl)-4-morpholinothieno[3,2-d]pyrimidine
- GDC-0980; Apitolisib; G 038390; G 038390.1; GDC 0980; GDC 0980.1; GNE 390; RG 7422